![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/luye-pharma-announces-us-fda-approval-of-erzofri-paliperidone-palmitate-extended-release-injectable-suspension-for-treating-schizophrenia-and-schizoaffective-disorder-302208155.html
https://www.biospectrumasia.com/news/25/23688/chinas-luye-pharma-partners-with-korea-based-myung-in-pharm-to-improve-alzheimers-related-dementia-treatment.html
https://www.biospectrumasia.com/news/25/22232/luye-pharma-duopharma-to-expand-accessibility-of-cholesterol-management-products-in-malaysia.html
https://www.pharmaceutical-technology.com/news/fda-schizophrenia-treatment-rykindo/
https://www.biospectrumasia.com/news/25/21113/luye-pharma-enters-into-new-partnership-with-ici-pakistan-for-mental-healthcare.html
https://www.prnewswire.com/news-releases/boan-biotech-to-present-the-pre-clinical-data-of-its-proprietary-cd3-t-cell-engager-platform-and-ceacd3-bispecific-antibody-at-world-bispecific-summit-301385115.html
https://en.prnasia.com/releases/apac/luye-pharma-and-towa-pharmaceutical-enter-strategic-collaboration-to-develop-and-commercialize-rivastigmine-multi-day-transdermal-patch-in-japan-308920.shtml